Abstract
PURPOSE: Standard automated perimetry has been the standard method for measuring visual field changes for several years. It can measure an individual's ability to detect a light stimulus from a uniformly illuminated background. In the management of glaucoma, the primary objective of perimetry is the identification and quantification of visual field abnormalities. It also serves as a longitudinal evaluation for the detection of disease progression. The development of artificial intelligence--based models capable of interpreting tests could combine technological development with improved access to healthcare. METHODS: In this observational, cross-sectional, descriptive study, we used an artificial intelligence-based model [Inception V3] to interpret gray-scale crops from standard automated perimetry that were performed in an ophthalmology clinic in the Brazilian Amazon rainforest between January 2018 and December 2022. RESULTS: The study included 1,519 standard automated perimetry test results that were performed using Humphrey HFA-II-i-750 (Zeiss Meditech). The Subsequently, 70%, 10%, and 20% of the dataset were used for training, validation, and testing, respectively. The model achieved 80% (68.23%-88.9%) sensitivity and 94.64% (88.8%-98%) specificity for detecting altered perimetry results. Furthermore, the area under the receiver operating characteristic curve was 0.93. CONCLUSIONS: The integration of artificial intelligence in the diagnosis, screening, and monitoring of pathologies represents a paradigm shift in ophthalmology, enabling significant improvements in safety, efficiency, availability, and accessibility of treatment.